Andrea Cavazzoni

11PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 27, 2026
Longitudinal Circulating Nerve Growth Factor in Pancreatic Ductal Adenocarcinoma: An Exploratory Study of Postoperative Recurrence and First-Line Disease Control.

|Apr 26, 2025
Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666.

Andrea Cavazzoni, Graziana Digiacomo, Roberta Alfieri

|Mar 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.

Silvia La Monica, Federica Vacondio, Kamal Eltayeb

|Nov 10, 2023
Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies.

Andrea Cavazzoni, Graziana Digiacomo

|Dec 11, 2022
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells.

Rita Terenziani, Maricla Galetti, Silvia La Monica

|Sep 09, 2022
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.

Rita Balsano, Zita Kruize, Martina Lunardi

Pageof 2

Frequent Collaborators

4 joint publications

Claudia Fumarola

4 joint publications

Roberta Alfieri

4 joint publications

Maricla Galetti

4 joint publications

Marcello Tiseo